UB Paderborn / Katalog / Suche / in CDI

Complications and Predictive Factors for Air Leak > 10 Days with Neoadjuvant Chemotherapy Followed by Pleurectomy/Decortication for Malignant Pleural Mesothelioma

Annals of surgical oncology, 2021-06, Vol.28 (6), p.3057-3065

2021

Volltextzugriff (PDF)

Relationship Between Physical Function and Health Utility in Patients Undergoing Surgical Treatment for Malignant Pleural Mesothelioma

Integrative cancer therapies, 2021, Vol.20, p.153473542110435-15347354211043508

2021

Volltextzugriff (PDF)

Pleural thickness after neoadjuvant chemotherapy is a prognostic factor in malignant pleural mesothelioma

The Journal of thoracic and cardiovascular surgery, 2019-01, Vol.157 (1), p.404-413

2019

Volltextzugriff (PDF)

Initial evaluation of nivolumab in patients with post-operative recurrence of malignant pleural mesothelioma

Japanese journal of clinical oncology, 2020-08, Vol.50 (8), p.920-925

2020

Volltextzugriff (PDF)

Control of air leakage during pleurectomy/decortication by the ventilation and anchoring method

General thoracic and cardiovascular surgery, 2022-08, Vol.70 (8), p.730-734

2022

Volltextzugriff (PDF)

Incidence and Risk Factors of Chest Wall Metastasis at Biopsy Sites in Patients with Malignant Pleural Mesothelioma

Cancers, 2022-09, Vol.14 (18), p.4356

2022

Volltextzugriff (PDF)

Clinical feature of diagnostic challenging cases for pleural biopsy in patient with malignant pleural mesothelioma

General thoracic and cardiovascular surgery, 2020-08, Vol.68 (8), p.820-827

2020

Volltextzugriff (PDF)

Long-term outcomes and risk factors of residual thoracic spaces after pleurectomy/decortication for mesothelioma

European journal of cardio-thoracic surgery, 2022-12, Vol.63 (1)

2022

Volltextzugriff (PDF)

Survival impact of thoracic cavity reduction during neoadjuvant chemotherapy in patients undergoing surgery for malignant pleural mesothelioma

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e20067-e20067

2019

Volltextzugriff (PDF)

Management of Spatially Localized Pulses in Two-Dimensional Composite Right- and Left-Handed Transmission Lines Periodically Loaded with Schottky Varactors

Japanese Journal of Applied Physics, 2008-08, Vol.47 (8R), p.6583

2008

Volltextzugriff (PDF)

Physical function and health-related quality of life in the convalescent phase in surgically treated patients with malignant pleural mesothelioma

Supportive care in cancer, 2019-11, Vol.27 (11), p.4107-4113

2019

Volltextzugriff (PDF)

Surgical Risk and Survival Associated With Less Invasive Surgery for Malignant Pleural Mesothelioma

Seminars in thoracic and cardiovascular surgery, 2019, Vol.31 (2), p.301-309

2019

Volltextzugriff (PDF)

Anomalous systemic arterial supply to normal basal segments of lung with anomalous V6

Nihon Kokyuki Geka Gakkai zasshi (Kyoto, 1992), 2024-01, Vol.38 (1), p.34-39

2024

Volltextzugriff (PDF)

Anomalous systemic arterial supply to normal basal segments of lung with anomalous V6

The Journal of the Japanese Association for Chest Surgery, 2024/01/15, Vol.38(1), pp.34-39

2024

Volltextzugriff (PDF)

CDK4/6 inhibitor and radiation therapy in malignant pleural mesothelioma

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e24326-e24326

2018

Volltextzugriff (PDF)

Quality of life and lung function after pleurectomy/decortication for malignant pleural mesothelioma

Interactive cardiovascular and thoracic surgery, 2021-10, Vol.33 (4), p.572-579

2021

Volltextzugriff (PDF)

Outcome of neo-adjuvant chemotherapy in 225 surgical candidates with malignant pleural mesothelioma

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.8548-8548

2019

Volltextzugriff (PDF)

Correlation between peripheral CD8+PD-1+ T cells diversity, tumor mutation burden (TMB) and T cell clones with anti-PD-1 antibody treatment of lung cancer patients: TCR repertoire as a novel predictive biomarker

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e14041-e14041

2019

Volltextzugriff (PDF)

Poor Prognostic Factors in Patients with Malignant Pleural Mesothelioma Classified as Pathological Stage IB According to the Eighth Edition TNM Classification

Annals of surgical oncology, 2018-06, Vol.25 (6), p.1572-1579

2018

Volltextzugriff (PDF)

The mTOR Signaling Pathway Is Associated With the Prognosis of Malignant Pleural Mesothelioma After Multimodality Therapy

Anticancer research, 2019-11, Vol.39 (11), p.6241-6247

2019

Volltextzugriff (PDF)

Three tumor markers for improved efficacy in the management of patients with malignant pleural mesothelioma

Journal of thoracic disease, 2020-11, Vol.12 (11), p.6712-6721

2020

Volltextzugriff (PDF)

The significance of RB expression in malignant pleural mesothelioma in multidisciplinary treatment including extrapleural pneumonectomy

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e20082-e20082

2016

Volltextzugriff (PDF)

Determining association between activation of mTOR signal pathway and patient with malignant pleural mesothelioma who underwent a multimodality therapy including extrapleural pneumonectomy

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e18543-e18543

2015

Volltextzugriff (PDF)

ERCC1 in patients with Malignant Pleural Mesothelioma (MPM) treated by neoadjuvant chemotherapy followed by extrapleural pneumonectomy (EPP)

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e18542-e18542

2015

Volltextzugriff (PDF)

A Retrospective Single-Institutional Analysis of the Usefulness of Pleural Effusion-Cell Block for Diagnosing Malignant Pleural Mesothelioma

Haigan, 2020/12/20, Vol.60(7), pp.972-978

2020

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Complications and Predictive Factors for Air Leak > 10 Days with Neoadjuvant Chemotherapy Followed by Pleurectomy/Decortication for Malignant Pleural Mesothelioma

Relationship Between Physical Function and Health Utility in Patients Undergoing Surgical Treatment for Malignant Pleural Mesothelioma

Pleural thickness after neoadjuvant chemotherapy is a prognostic factor in malignant pleural mesothelioma

Initial evaluation of nivolumab in patients with post-operative recurrence of malignant pleural mesothelioma

Control of air leakage during pleurectomy/decortication by the ventilation and anchoring method

Incidence and Risk Factors of Chest Wall Metastasis at Biopsy Sites in Patients with Malignant Pleural Mesothelioma

Clinical feature of diagnostic challenging cases for pleural biopsy in patient with malignant pleural mesothelioma

Long-term outcomes and risk factors of residual thoracic spaces after pleurectomy/decortication for mesothelioma

Survival impact of thoracic cavity reduction during neoadjuvant chemotherapy in patients undergoing surgery for malignant pleural mesothelioma

Management of Spatially Localized Pulses in Two-Dimensional Composite Right- and Left-Handed Transmission Lines Periodically Loaded with Schottky Varactors

Physical function and health-related quality of life in the convalescent phase in surgically treated patients with malignant pleural mesothelioma

Surgical Risk and Survival Associated With Less Invasive Surgery for Malignant Pleural Mesothelioma

Anomalous systemic arterial supply to normal basal segments of lung with anomalous V6

Anomalous systemic arterial supply to normal basal segments of lung with anomalous V6

CDK4/6 inhibitor and radiation therapy in malignant pleural mesothelioma

Quality of life and lung function after pleurectomy/decortication for malignant pleural mesothelioma

Outcome of neo-adjuvant chemotherapy in 225 surgical candidates with malignant pleural mesothelioma

Correlation between peripheral CD8+PD-1+ T cells diversity, tumor mutation burden (TMB) and T cell clones with anti-PD-1 antibody treatment of lung cancer patients: TCR repertoire as a novel predictive biomarker

Poor Prognostic Factors in Patients with Malignant Pleural Mesothelioma Classified as Pathological Stage IB According to the Eighth Edition TNM Classification

The mTOR Signaling Pathway Is Associated With the Prognosis of Malignant Pleural Mesothelioma After Multimodality Therapy

Three tumor markers for improved efficacy in the management of patients with malignant pleural mesothelioma

The significance of RB expression in malignant pleural mesothelioma in multidisciplinary treatment including extrapleural pneumonectomy

Determining association between activation of mTOR signal pathway and patient with malignant pleural mesothelioma who underwent a multimodality therapy including extrapleural pneumonectomy

ERCC1 in patients with Malignant Pleural Mesothelioma (MPM) treated by neoadjuvant chemotherapy followed by extrapleural pneumonectomy (EPP)

A Retrospective Single-Institutional Analysis of the Usefulness of Pleural Effusion-Cell Block for Diagnosing Malignant Pleural Mesothelioma

Suchergebnisse filtern